D Kos1, M Duportail, Mb D'hooghe, G Nagels, E Kerckhofs. 1. Department of Rehabilitation Research, Vrije Universiteit Brussel, Brussels, Belgium, Department of Occupational Therapy, National MS Centre, Melsbroek, Belgium. Daphne.Kos@vub.ac.be
Abstract
OBJECTIVE: To establish the efficacy of a multidisciplinary fatigue management programme (MFMP) in MS. Method Fifty-one subjects with MS were randomly allocated to group A, who only received the four weeks MFMP, or group B receiving a placebo intervention programme first and the MFMP after 6 months. In both groups, assessment was performed at baseline, 3 weeks and 6 months after the programmes and included Modified Fatigue Impact Scale (MFIS), Fatigue Severity Scale (FSS), MS Self-Efficacy scale (MSSE), Mental Health Inventory (MHI) and Impact on Participation and Autonomy (IPA). RESULTS: The MFIS showed a significant change over time (F(4,152) = 3.346, P = 0.012), which was similar in both groups (time*group interaction: F(4,152) = 1.094, P = 0.361). A clinically relevant reduction of MFIS score of 10 points or more was found in 17% of individuals following the MFMP, compared to 44% after the placebo intervention programme (P = 0.06). Compared to no intervention, a significant effect of the MFMP after 6 months (P = 0.003) was found in five participants (31%). No significant changes in FSS, MSSE, MHI and IPA, in both groups, were found. CONCLUSION: Although an additional effect was found, the multidisciplinary fatigue management programme showed no efficacy in reducing the impact of fatigue compared to a placebo intervention programme.
RCT Entities:
OBJECTIVE: To establish the efficacy of a multidisciplinary fatigue management programme (MFMP) in MS. Method Fifty-one subjects with MS were randomly allocated to group A, who only received the four weeks MFMP, or group B receiving a placebo intervention programme first and the MFMP after 6 months. In both groups, assessment was performed at baseline, 3 weeks and 6 months after the programmes and included Modified Fatigue Impact Scale (MFIS), Fatigue Severity Scale (FSS), MS Self-Efficacy scale (MSSE), Mental Health Inventory (MHI) and Impact on Participation and Autonomy (IPA). RESULTS: The MFIS showed a significant change over time (F(4,152) = 3.346, P = 0.012), which was similar in both groups (time*group interaction: F(4,152) = 1.094, P = 0.361). A clinically relevant reduction of MFIS score of 10 points or more was found in 17% of individuals following the MFMP, compared to 44% after the placebo intervention programme (P = 0.06). Compared to no intervention, a significant effect of the MFMP after 6 months (P = 0.003) was found in five participants (31%). No significant changes in FSS, MSSE, MHI and IPA, in both groups, were found. CONCLUSION: Although an additional effect was found, the multidisciplinary fatigue management programme showed no efficacy in reducing the impact of fatigue compared to a placebo intervention programme.
Authors: Lisa Corbin; Rebecca Childs; Caitlin Dilli; Mary K Christian; Ban Wong; Daisy Dong-Cedar; Benzi M Kluger Journal: Med Acupunct Date: 2016-08-01
Authors: Peter W Thomas; Sarah Thomas; Paula Kersten; Rosemary Jones; Alison Nock; Vicky Slingsby; Colin Green; Roger Baker; Kate Galvin; Charles Hillier Journal: BMC Neurol Date: 2010-06-16 Impact factor: 2.474
Authors: Jodie K Haselkorn; Christina Hughes; Alex Rae-Grant; Lily Jung Henson; Christopher T Bever; Albert C Lo; Theodore R Brown; George H Kraft; Thomas Getchius; Gary Gronseth; Melissa J Armstrong; Pushpa Narayanaswami Journal: Neurology Date: 2015-11-24 Impact factor: 9.910
Authors: Maria Janina Wendebourg; Lena Katharina Feddersen; Stephanie Lau; Sascha Köpke; Rona Moss-Morris; Christoph Heesen; Jana Pöttgen Journal: Int J MS Care Date: 2016 May-Jun
Authors: Farrah J Mateen; Andre C Vogel; Tamara B Kaplan; Gladia C Hotan; Sara J Grundy; Kathryn B Holroyd; Natalie Manalo; Matthew Stauder; Aleksandar Videnovic Journal: J Neurol Date: 2020-04-24 Impact factor: 4.849